世界の融解生検市場2023-2030:生検ルート別(経直腸、経会陰)、エンドユーザー別(病院、診断センター、外来医療センター)、地域別

【英語タイトル】Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV121)・商品コード:GRV23NOV121
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

融解生検市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の融解生検市場規模は2030年までに1,115.6百万米ドルに達し、予測期間中の年平均成長率は8.6%で推移すると予測されています。前立腺癌の有病率の増加、標的生検に対する需要の高まり、前立腺癌治療における多波長MRIの利用率の上昇は、予測期間中に市場を牽引すると予想される要因です。さらに、日常的な治療介入の価値に対する意識の高まりや新たな償還政策などの要因が、融合生検市場の需要を促進すると予測されています。

TRUS生検、PSA検査、直腸指診などの他の従来技術に比べ、標的融合生検は前立腺病変の描出における感度と特異性が高いため、市場成長に寄与すると予想されます。侵攻性腫瘍の診断における融解生検システムの信頼性と再現性により、前立腺生検の標準ツールとなることが期待されます。PI-RADSやグリソンスコアのような標準的な画像分類システムの導入と相まって、前立腺MRIの読影に関する専門知識を習得する放射線科医が増加していることが、標的MR/超音波融合生検システムの利用率を高めています。

研究への資金提供、意識の普及、前立腺がんに関する集団検診プログラムの実施といった点で、政府のイニシアチブの増加が市場の成長に重要な役割を果たすと期待されています。市場参入企業が採用する成長戦略には、この競争の激しい領域で成長を促進・維持するためのパートナーシップ、製品発表、展示会や会議への参加、買収などがあります。

融解生検市場レポートハイライト

- 前立腺融合生検のゴールドスタンダードかつ一般的な方法であるため、経直腸部門が2022年に最大の市場シェアを獲得しました。

- 経直腸セグメントは、安全性、診断効率、腹側前立腺領域へのアクセス能力により、予測期間中に最も速い速度で成長する見込みです。

- 教育病院におけるMR/US標的融合生検システムの調達率増加などの要因により、病院セグメントが2022年に最大の収益シェアを占めました。

- 診断センター部門は、予測期間中に大幅な拡大が見込まれます。待ち時間の短縮、コスト効率、発展途上の償還パラダイムがこのセグメントの成長を促進すると予想される要因です。

- 北米は2022年に最大の市場シェアを占め、予測期間中もその優位性を維持すると予測されています。

- アジア太平洋地域は、特に日本、オーストラリア、中国などの泌尿器科医の間でMRI/US標的融合生検システムの感度と特異性に関する認識が高まっているなどの要因により、予測期間中のCAGRが9.9%になると予測されています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の融解生検市場変数・傾向・範囲
第4章 世界の融解生検市場:生検ルート別予測・傾向分析
第5章 世界の融解生検市場:エンドユーザー別予測・傾向分析
第6章 世界の融解生検市場:地域別予測・傾向分析
第7章 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Biopsy route
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Biopsy route outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Fusion Biopsy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of prostate cancer
3.4.1.2. Technological advancements in fusion imaging modalities
3.4.1.3. Increasing funds and investments by public and private sector
3.4.2. Market restraint analysis
3.4.2.1. High cost of fusion biopsy system
3.4.2.2. Liquid biopsy system
3.5. Fusion Biopsy Market Analysis Tools
3.5.1. Industry analysis – Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
3.5.5. COVID-19 Impact Analysis
Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Transrectal
4.1.2. Transperineal
4.2. Biopsy Route Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Transrectal
4.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
4.5.2. Transperineal
4.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic centers
5.1.3. Ambulatory care centers
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Fusion Biopsy Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
5.5.2. Diagnostic centers
5.5.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
5.5.3. Ambulatory care centers
5.5.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts and Trend Analysis, 2022 to 2030:
6.7. North America
6.7.1. U.S.
6.7.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.7.2. Canada
6.7.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8. Europe
6.8.1. UK
6.8.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.3. France
6.8.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.4. Italy
6.8.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.5. Spain
6.8.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.6. Denmark
6.8.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.7. Sweden
6.8.7.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.8.8. Norway
6.8.8.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Japan
6.9.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.2. China
6.9.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.3. India
6.9.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.4. South Korea
6.9.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.5. Thailand
6.9.5.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.9.6. Australia
6.9.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.10.3. Argentina
6.10.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.11.4. Kuwait
6.11.4.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competitive Categorization
7.2.1. Innovators
7.2.2. Market leaders
7.2.3. Emerging players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company market share/ranking, by region
7.4.3. Competitive dashboard analysis
7.4.3.1. Market differentiators
7.4.3.2. Synergy analysis: major deals and strategic alliances
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Funding outlook
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.5. Supplier ranking
7.5.6. Key company profiled
7.5.7. Eigen
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Koninklijke Philips N.V.
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Hitachi, Ltd.
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. MedCom
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. ESAOTE SPA
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. KOELIS
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Focal Healthcare
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. GeoScan Medical
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
7.5.15. UC-Care Medical Systems Ltd.
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Product benchmarking
7.5.15.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America fusion biopsy market, by region, 2018 - 2030 (USD Million)
Table 3 North America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 4 North America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 6 U.S. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 8 Canada fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe fusion biopsy market, by region, 2018 - 2030 (USD Million)
Table 10 Europe fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 11 Europe fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.K. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 13 U.K. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 14 Germany fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 15 Germany fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 16 Italy fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 17 Italy fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 18 France fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 19 France fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 21 Spain fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 22 Denmark fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 23 Denmark fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 24 Sweden fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 25 Sweden fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 26 Norway fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 27 Norway fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific fusion biopsy market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 30 Asia Pacific fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 31 Japan fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 32 Japan fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 33 India fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 34 India fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 35 China fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 36 China fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 37 Thailand fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 38 Thailand fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 39 South Korea fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 40 South Korea fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 42 Australia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America fusion biopsy market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 45 Latin America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 46 Brazil fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 47 Brazil fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 49 Mexico fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 51 Argentina fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 52 MEA fusion biopsy market, by region, 2018 - 2030 (USD Million)
Table 53 MEA fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 54 MEA fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 55 South Africa fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 56 South Africa fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 60 UAE fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
Table 62 Kuwait fusion biopsy market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1. Market research process
Fig. 2. Data triangulation techniques
Fig. 3. Primary research pattern
Fig. 4. Primary interviews in North America
Fig. 5. Primary interviews in Europe
Fig. 6. Primary interviews in APAC
Fig. 7. Primary interviews in Latin America
Fig. 8. Primary interviews in MEA
Fig. 9. Market research approaches
Fig. 10. Value-chain-based sizing & forecasting
Fig. 11. QFD modeling for market share assessment
Fig. 12. Market formulation & validation
Fig. 13. Fusion biopsy market: market outlook
Fig. 14. Fusion biopsy market competitive insights
Fig. 15. Parent market outlook
Fig. 16. Related/ancillary market outlook
Fig. 17. Penetration and growth prospect mapping
Fig. 18. Industry value chain analysis
Fig. 19. Fusion biopsy market driver impact
Fig. 20. Fusion biopsy market restraint impact
Fig. 21. Fusion biopsy market strategic initiatives analysis
Fig. 22. Fusion biopsy market: biopsy route movement analysis
Fig. 23. Fusion biopsy market: biopsy route outlook and key takeaways
Fig. 24. Transrectal market estimates and forecast, 2018 - 2030
Fig. 25. Transperineal market estimates and forecast, 2018 - 2030
Fig. 26. Fusion biopsy market: end-use movement analysis
Fig. 27. Fusion biopsy market: end-use outlook and key takeaways
Fig. 28. Hospitals market estimates and forecast, 2018 - 2030
Fig. 29. Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 30. Ambulatory care centers market estimates and forecast, 2018 - 2030
Fig. 31. Fusion biopsy market: regional movement analysis
Fig. 32. Fusion biopsy market: regional outlook and key takeaways
Fig. 33. Fusion biopsy market share and leading players
Fig. 34. North America market share and leading players
Fig. 35. Europe market share and leading players
Fig. 36. Asia Pacific market share and leading players
Fig. 37. Latin America market share and leading players
Fig. 38. Middle East & Africa market share and leading players
Fig. 39. North America: SWOT
Fig. 40. Europe SWOT
Fig. 41. Asia Pacific SWOT
Fig. 42. Latin America SWOT
Fig. 43. MEA SWOT
Fig. 44. North America, by country
Fig. 45. North America
Fig. 46. North America market estimates and forecast, 2018 - 2030
Fig. 47. U.S.
Fig. 48. U.S. market estimates and forecast, 2018 - 2030
Fig. 49. Canada
Fig. 50. Canada market estimates and forecast, 2018 - 2030
Fig. 51. Europe
Fig. 52. Europe market estimates and forecast, 2018 - 2030
Fig. 53. UK
Fig. 54. UK market estimates and forecast, 2018 - 2030
Fig. 55. Germany
Fig. 56. Germany market estimates and forecast, 2018 - 2030
Fig. 57. France
Fig. 58. France market estimates and forecast, 2018 - 2030
Fig. 59. Italy
Fig. 60. Italy market estimates and forecast, 2018 - 2030
Fig. 61. Spain
Fig. 62. Spain market estimates and forecast, 2018 - 2030
Fig. 63. Denmark
Fig. 64. Denmark market estimates and forecast, 2018 - 2030
Fig. 65. Sweden
Fig. 66. Sweden market estimates and forecast, 2018 - 2030
Fig. 67. Norway
Fig. 68. Norway market estimates and forecast, 2018 - 2030
Fig. 69. Asia Pacific
Fig. 70. Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 71. China
Fig. 72. China market estimates and forecast, 2018 - 2030
Fig. 73. Japan
Fig. 74. Japan market estimates and forecast, 2018 - 2030
Fig. 75. India
Fig. 76. India market estimates and forecast, 2018 - 2030
Fig. 77. Thailand
Fig. 78. Thailand market estimates and forecast, 2018 - 2030
Fig. 79. South Korea
Fig. 80. South Korea market estimates and forecast, 2018 - 2030
Fig. 81. Australia
Fig. 82. Australia market estimates and forecast, 2018 - 2030
Fig. 83. Latin America
Fig. 84. Latin America market estimates and forecast, 2018 - 2030
Fig. 85. Brazil
Fig. 86. Brazil market estimates and forecast, 2018 - 2030
Fig. 87. Mexico
Fig. 88. Mexico market estimates and forecast, 2018 - 2030
Fig. 89. Argentina
Fig. 90. Argentina market estimates and forecast, 2018 - 2030
Fig. 91. Middle East and Africa
Fig. 92. Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 93. South Africa
Fig. 94. South Africa market estimates and forecast, 2018 - 2030
Fig. 95. Saudi Arabia
Fig. 96. Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 97. UAE
Fig. 98. UAE market estimates and forecast, 2018 - 2030
Fig. 99. Kuwait
Fig. 100. Kuwait market estimates and forecast, 2018 - 2030
Fig. 101. Participant categorization - fusion biopsy market
Fig. 102. Market share of key market players - fusion biopsy market

★調査レポート[世界の融解生検市場2023-2030:生検ルート別(経直腸、経会陰)、エンドユーザー別(病院、診断センター、外来医療センター)、地域別] (コード:GRV23NOV121)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の融解生検市場2023-2030:生検ルート別(経直腸、経会陰)、エンドユーザー別(病院、診断センター、外来医療センター)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆